| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/02/2009 | US20090088569 2-amino-imidazo[4,5-d]pyridazin-4-ones, their preparation, and their use as pharmaceutical compositions |
| 04/02/2009 | US20090088437 nicotinic receptor agonists such as 3-{[(1S,4S)-5-Methyl-2,5-diazabicyclo[2.2.1]hept-2-yl]carbonyl}-1,2-benzisothiazole, used for the treatment of brain disorders |
| 04/02/2009 | US20090087409 Viral Polymerase Inhibitors |
| 04/02/2009 | US20090087378 Positron Tomography Method and Positron-Emitting Compound to Be Used Therein |
| 04/02/2009 | CA2700841A1 Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| 04/02/2009 | CA2700277A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 04/02/2009 | CA2700113A1 Indazole acrylic acid amide compound |
| 04/02/2009 | CA2697580A1 Octahydropentalene compounds as chemokine receptor antagonists |
| 04/01/2009 | EP2042504A1 Fused azole-pyrimidine derivatives |
| 04/01/2009 | EP2042503A1 Compound having acidic group which may be protected, and use thereof |
| 04/01/2009 | EP2042502A1 Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
| 04/01/2009 | EP2042501A1 Novel compound having affinity for amyloid |
| 04/01/2009 | EP2042500A1 N-[4-(1-H-pyrazolo[3,4-c]pyridin-4-yl)phenyl]-N'-[(hetero)aryl]-urea compounds, pharmaceutical compositions comprising them, their preparation and their use as Tie2-kinase inhibitors |
| 04/01/2009 | EP2041134A1 Novel 1,4-diaza-bicycloý3.2.2¨nonyl pyrimidinyl derivatives and their medical use |
| 04/01/2009 | EP2041133A1 Derivatives of imidazo [1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics |
| 04/01/2009 | EP2041132A2 New compounds |
| 04/01/2009 | EP2041131A1 Azaindole derivatives with a combination of partial nicotinic acetylcholine receptor agonism and dopamine reuptake inhibition |
| 04/01/2009 | EP2041130A1 Novel hydrate form of moxifloxacin monohydrochloride |
| 04/01/2009 | EP2041127A2 Indole compounds |
| 04/01/2009 | EP2040706A2 Modulators of muscarinic receptors |
| 04/01/2009 | EP2040703A2 Derivatives of 2-benzoyl-imidazopyridines, preparation method thereof and use of same in therapeutics |
| 04/01/2009 | EP2040698A2 Oxime compounds and the use thereof |
| 04/01/2009 | EP2040549A2 Benzofuro-and benzothienopyryimidine modulators of the histamine h4 receptor |
| 04/01/2009 | EP2040546A2 Tyrosine kinase inhibitors |
| 04/01/2009 | EP1653961A4 Inhibitors of akt activity |
| 04/01/2009 | EP1594869B9 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof |
| 04/01/2009 | CN101400680A Spiroindolinone derivatives |
| 04/01/2009 | CN101400679A Spiroindolinone derivatives |
| 04/01/2009 | CN101400678A Thiophene-carboxamides useful as inhibitors of protein kinases |
| 04/01/2009 | CN101400674A Antibiotic compounds |
| 04/01/2009 | CN101400668A 2-(cyclic amino)-pyrimidone derivatives as TPK1 inhibitors |
| 04/01/2009 | CN101397298A Acidamide substituted pyrrole[2,3-b] pyridines compounds, preparation method and use thereof |
| 04/01/2009 | CN100473654C S type 4-substituted hydroxypyranoindolidine compound and derivatives and preparation thereof |
| 04/01/2009 | CN100473651C Pyrazolyl-substituted heterocycles and use thereof as phytosanitary products |
| 03/31/2009 | US7511159 Azetidine ring compounds and drugs comprising the same |
| 03/31/2009 | US7511145 Bicyclic heteroaryl derivatives |
| 03/31/2009 | US7511138 Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles |
| 03/31/2009 | US7511058 3-benzyl-7-(4-bromo-2-chlorophenylamino)-8-chloro-[1,2,4]triazolo [4,3-a]pyridine-6-carboxylic acid cyclopropylmethoxyamide; mitogen activated protein kinase inhibitors; used in the treatment of hyperproliferative diseases, such as cancer and inflammation in mammals; synergistic use |
| 03/31/2009 | US7511057 Triazolopyridinylsulfanyl derivatives as p38 MAP kinase inhibitors |
| 03/31/2009 | US7511055 Naphthyridin derivatives |
| 03/31/2009 | US7511053 Spiroazacyclic compounds as monoamine receptor modulators |
| 03/31/2009 | US7511050 hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors; avoiding adverse effects such as hepatotoxicity and cutaneous flushing; low dosage; 2-bromo-8-methyl-4-pentyl-1,4-dihydro-5H-[1,2,4]triazolo[5,1-i]purin-5-one; to treat cardiovascular disorders |
| 03/31/2009 | US7511048 Hyperproliferative disorders; packages |
| 03/31/2009 | US7511047 Kinase inhibitors |
| 03/31/2009 | US7511044 Vanilloid receptor ligands and their use in treatments |
| 03/31/2009 | US7511041 Fused azole-pyrimidine derivatives |
| 03/31/2009 | US7511040 Aurora (serine/threonine) kinase inhibitor; antiproliferative agent; small-molecule; solid tumor, leukemia; with other active ingredients |
| 03/31/2009 | US7511038 Pyridazin-3(2H)-one derivatives and their use as PDE4 inhibitors |
| 03/31/2009 | US7510781 Organic luminescence device (OLED) containing both a 5,5'-spirobi(dibenzosilole) compound and a diarylaminofluorene compound; spiro compounds have improved electron-transporting property, luminescence, and durability |
| 03/31/2009 | US7510702 Condensation aerosol for delivery of a drug selected from the group consisting of indomethacin, ketoprofen, celcoxib, rofecoxib, meclofenamic acid, fenoprofen, diflunisal, tolfenamic acid, naproxen, ibuprofen, flurbiprofen and nabumetone |
| 03/31/2009 | CA2307285C Agent for prophylaxis and treatment of glaucoma |
| 03/26/2009 | WO2009039362A2 Chiral synthesis of diazepinoquinolines |
| 03/26/2009 | WO2009038847A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
| 03/26/2009 | WO2009038812A1 Condensed piperidine derivatives useful as vanilloid receptor ligands |
| 03/26/2009 | WO2009038385A2 Novel compounds having indazole frameworks, methods for preparing the same and pharmaceutical composition comprising the same |
| 03/26/2009 | WO2009038057A1 Nitrogenated fused-ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 03/26/2009 | WO2009037556A1 New agents for the treatment of the low urinary tract dysfunctions |
| 03/26/2009 | WO2009037394A2 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 03/26/2009 | WO2009037283A1 Method for producing substrates coated with rylene tetracarbolic acid diimides |
| 03/26/2009 | WO2009037222A1 Diacylglycerol acyltransferase inhibitors |
| 03/26/2009 | WO2009037168A1 Heterocyclic antiviral compounds |
| 03/26/2009 | WO2009037001A2 Novel tetrahydrofusedpyridines as histone deacetylase inhibitors |
| 03/26/2009 | WO2009016460A3 Pyrazole compounds and their use as raf inhibitors |
| 03/26/2009 | WO2009010129A8 Bispidon ligands and the metal complexes thereof |
| 03/26/2009 | WO2009006389A8 Pyrimidine derivatives useful as raf kinase inhibitors |
| 03/26/2009 | WO2008145688A3 Pyrrolopyridine compounds, process for their preparation, and their use as medicaments |
| 03/26/2009 | WO2008141731A3 Inhibitors of hypoxia inducible factor (hif) useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 03/26/2009 | WO2008139288A3 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials |
| 03/26/2009 | WO2008135791A8 Imidazoquinolines with immuno-modulating properties |
| 03/26/2009 | US20090082565 Methods of preparing quinolone analogs |
| 03/26/2009 | US20090082392 Substituted Carboxylic Acids |
| 03/26/2009 | US20090082390 Piperidine compounds for use as orexin receptor antagonist |
| 03/26/2009 | US20090082372 Arylmethylene Substituted N-Acyl-Beta-Amino Alcohols |
| 03/26/2009 | US20090082368 Methods of modulating neurotrophin-mediated activity |
| 03/26/2009 | US20090082358 Vanilloid receptor ligands and their use in treatments |
| 03/26/2009 | US20090082357 Prolyl Hydroxylase Inhibitors |
| 03/26/2009 | US20090082346 Substituted Pyrrolo-Pyrazole Derivatives as Kinase Inhibitors |
| 03/26/2009 | US20090081165 Bicyclic heteroaryl derivatives |
| 03/26/2009 | US20090078312 Verfahren zur herstellung von mit rylentetracarbonsaeurediimiden beschichteten substraten |
| 03/26/2009 | CA2700306A1 Chiral synthesis of diazepinoquinolines |
| 03/26/2009 | CA2700160A1 Fluoro-containing derivatives of hydrogenated pyrido[4,3-b]indoles with neuroprotective and cognition enhancing properties, process for preparing, and use |
| 03/26/2009 | CA2696725A1 Pyridine derivatives and methods of use thereof |
| 03/26/2009 | CA2696508A1 Diacylglycerol acyltransferase inhibitors |
| 03/26/2009 | CA2693116A1 6-cycloamino-s-(pyridazin-4-yl)imidazo[1,2-b]-pyridazine and derivatives thereof preparation and therapeutic application thereof |
| 03/26/2009 | CA2691031A1 N-(2-(hetaryl)aryl)arylsulfonamides and n-(2-(hetaryl)hetaryl)arylsulfonamides |
| 03/25/2009 | EP2039694A1 CGRP receptor antagonists |
| 03/25/2009 | EP2039685A2 Heterobicyclic compounds as P38 inhibitors |
| 03/25/2009 | EP2039683A2 Vasculostatic agents and methods of use thereof |
| 03/25/2009 | EP2038356A1 Liquid hardening |
| 03/25/2009 | EP2038281A2 Nicotinic agonists selective for the alpha7 receptor subtype, the process for the preparation thereof and pharmaceutical compositions therefrom |
| 03/25/2009 | EP2038280A2 Fused, tricyclic sulfonamide inhibitors of gamma secretase |
| 03/25/2009 | EP2038279A2 Substituted pyrazolo [1,5- alpha] pyridine compounds and their methods of use |
| 03/25/2009 | EP2038272A2 Pyridinonyl pdk1 inhibitors |
| 03/25/2009 | EP2037916A2 Pure isomers of tritoqualine |
| 03/25/2009 | EP2037915A2 Phenol derivatives for the treatment of respiratory diseases |
| 03/25/2009 | EP1841765B1 Imidazo[4,5-c]pyridine compound and method of antiviral treatment |
| 03/25/2009 | EP1756063A4 Amido compounds and their use as pharmaceuticals |
| 03/25/2009 | EP1636218B1 Thiazolylpiperidine derivatives as mtp inhibitors |
| 03/25/2009 | EP1555265B1 7-phenyl pyrazolopyridine compounds |
| 03/25/2009 | CN101395157A Pyrrazole derivatives as sigma receptors antagonists |